BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

In the clinic for April 5, 2023

April 5, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: C2n Diagnostics.
Read More

Financings for April 5, 2023

April 5, 2023
Med-tech firms raising money in public or private financings, including: Celularity, Felix Health, G Medical Innovations, Occlutech.
Read More

Appointments and advancements for April 5, 2023

April 5, 2023
New hires and promotions in the med-tech industry, including: Bioventus, Jenavalve, Nugen, Sparingvision, Wondr Health.
Read More

Regulatory actions for April 5, 2023

April 5, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acasti, Aim, Amarin, Astellas, Caribou, Gennova, Hutchmed, Pfizer, Phathom, Scisparc, Seagen, Shionogi.
Read More

Other news to note for April 5, 2023

April 5, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acelrx, Aeterna, Alora, Anagram, Biomed X, Biotheryx, Cyclerion, Dr. Reddy’s, Eagle, Ginkgo, Incyte, Liminal, Merck KGaA, Scilex, Sorrento, Stridebio.
Read More

In the clinic for April 5, 2023

April 5, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzamend, Alterity, Arrowhead, Axial, Bioarctic, EIP, Eisai, Innocare, Iomx, Lundbeck, Lynk, Mythic, Otsuka, Precision, Skye, Sobi, Takeda.
Read More

Financings for April 5, 2023

April 5, 2023
Biopharmas raising money in public or private financings, including:  Addex, Celularity, Cellectis, Protagonist, Transcode.
Read More

Appointments and advancements for April 5, 2023

April 5, 2023
New hires and promotions in the biopharma industry, including: Biorchestra, Clearside, Clexbio, Generation, Rocket, Sisaf, Sparingvision, Surrozen, Walden.
Read More

Appointments and advancements for April 4, 2023

April 4, 2023
New hires and promotions in the biopharma industry in Asia-Pacific, including: Bioduro-Sundia, Hanall.
Read More

Regulatory actions for April 4-10, 2023

April 4, 2023
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Aim Immunotech, Astellas, Brim, Edesa, Everest Medicines, Gennova, Hutchmed, Inflarx, Seagen, Shionogi.
Read More
Previous 1 2 … 814 815 816 817 818 819 820 821 822 … 1791 1792 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Regulatory actions for May 5, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing